Fasting Insulin

Fasting insulin is a blood marker that measures the amount of insulin circulating in your bloodstream after you have not eaten for at least eight hours. Insulin is a hormone made by the pancreas that acts like a “key,” allowing glucose (sugar) from the blood to enter your cells where it can be used for energy or stored for later. Even when you are not eating, your body needs a small, steady amount of insulin to keep blood glucose within a healthy range and to regulate how the liver releases stored glucose.

Measuring insulin in the fasting state gives insight into your body’s baseline insulin demand, without the immediate influence of a recent meal. In a metabolically healthy state, fasting insulin is relatively low because cells respond efficiently to insulin’s signal. When cells become less responsive — known as insulin resistance — the pancreas compensates by producing more insulin, even at rest. This can keep blood glucose looking “normal” for years, while insulin levels quietly rise in the background.

Because of this, fasting insulin often changes earlier than fasting glucose. Two people can have the same normal fasting glucose, but very different fasting insulin levels, reflecting very different underlying metabolic states. This makes fasting insulin especially valuable in functional and preventative medicine, where the goal is to detect early dysfunction and address root causes before disease develops.

Fasting insulin is central to understanding metabolic health, energy balance, and long-term disease risk. Chronically elevated fasting insulin is a hallmark of insulin resistance, a condition in which muscle, liver, and fat cells do not respond efficiently to insulin. To compensate, the pancreas increases insulin output to keep blood glucose in range. Over time, this high-insulin state places stress on the pancreas and disrupts normal metabolism.

Persistently high insulin levels are strongly associated with an increased risk of type 2 diabetes, metabolic syndrome, and cardiovascular disease. High insulin promotes fat storage — particularly visceral (abdominal) fat — which further worsens insulin resistance, creating a self-reinforcing cycle. Insulin also affects blood vessel function, inflammation, and lipid metabolism, helping explain why insulin resistance often clusters with high triglycerides, low HDL cholesterol, and elevated blood pressure.

Beyond blood sugar, insulin is a growth-promoting hormone. Excess insulin can influence hormonal balance, appetite regulation, and energy levels. Many people with elevated fasting insulin experience symptoms such as increased hunger, energy crashes, difficulty losing weight, or strong cravings for carbohydrates, even when blood glucose tests appear normal.

On the other end of the spectrum, very low fasting insulin may reflect reduced insulin production, inadequate energy intake, or issues with pancreatic function. While low insulin is less common, it can impair the body’s ability to maintain stable blood glucose between meals, potentially leading to fatigue, shakiness, or light-headedness.

Because fasting insulin sits upstream of many metabolic pathways, it provides a more sensitive and earlier window into metabolic stress than glucose alone. Tracking and addressing abnormal fasting insulin supports not only diabetes prevention, but also cardiovascular health, hormonal balance, and long-term metabolic resilience.

Dietary factors
Diet strongly influences insulin demand. Diets high in refined carbohydrates and added sugars — such as sweetened beverages, pastries, white bread, and ultra-processed snacks — drive frequent insulin release and can raise baseline fasting insulin over time. In contrast, meals rich in fibre, protein, and healthy fats slow glucose absorption and reduce insulin spikes. Examples include vegetables, legumes, whole grains, nuts, seeds, olive oil, eggs, and fatty fish. Excessive calorie intake, even from “healthy” foods, can also increase insulin if it leads to ongoing energy surplus.

Lifestyle factors
Physical activity is one of the most powerful regulators of insulin sensitivity. Regular movement helps muscles take up glucose with less insulin, lowering fasting levels over time. Sedentary behaviour reduces this effect. Sleep and stress also matter: chronic sleep deprivation and ongoing psychological stress raise stress hormones such as cortisol, which can interfere with insulin action and push fasting insulin higher.

Related biomarkers and physiology
Fasting insulin often shifts alongside fasting glucose, HbA1c, triglycerides, HDL cholesterol, and waist circumference. Elevated insulin commonly appears before these markers become abnormal. Liver health is also relevant, as the liver plays a key role in glucose release and insulin clearance.

Micronutrient impacts
Certain micronutrients support insulin signalling. Magnesium is involved in glucose transport and insulin receptor function, while chromium helps enhance insulin’s action at the cellular level. Low intakes or deficiencies may impair insulin sensitivity.

Environmental influences
Exposure to endocrine-disrupting chemicals — found in some plastics, pesticides, and industrial pollutants — has been linked to impaired insulin signalling. These exposures may subtly increase insulin resistance over time, especially when combined with poor diet and lifestyle factors.

If your results are high

If your fasting insulin is elevated, the goal is to reduce insulin demand and improve insulin sensitivity.

Diet:

• Focus on meals built around vegetables, lean proteins, and healthy fats.

• Aim for high-fibre carbohydrate sources such as legumes, oats, quinoa, and vegetables, while limiting refined grains and added sugars.

• Include protein at each meal and 2–3 servings of fatty fish per week.

• Avoid sugary drinks and frequent snacking.

Lifestyle:

• Accumulate at least 150 minutes per week of moderate-intensity activity, combining aerobic exercise with resistance training.

• Prioritise regular sleep and stress-management practices, as both strongly affect insulin action.

Supplements:

• Magnesium and chromium may support insulin sensitivity in those with low intake.

• Supplement use should be discussed with a healthcare professional.

Additional tests:

• Further assessment may include HbA1c

• fasting glucose

• an oral glucose tolerance test

• or lipid markers to better understand overall metabolic risk

If your results are low

Low fasting insulin often indicates excellent insulin sensitivity and good metabolic health, especially in lean individuals. However, context is key as in combination with high blood sugar, it can signify pancreatic exhaustion, such as in type 1 diabetes, or damage.

Additional tests to consider
Tests such as C-peptide or insulin-related antibodies may be used to further evaluate insulin production and pancreatic function under medical supervision.

1. Xun, P., Wu, Y., He, Q., & He, K. (2013). Fasting insulin concentrations and incidence of hypertension, stroke, and coronary heart disease: A meta-analysis of prospective cohort studies. The American Journal of Clinical Nutrition, 98(6), 1543–1554. https://doi.org/10.3945/ajcn.113.065565

2. Fatahi, S., Nazary-Vannani, A., Sohouli, M. H., et al. (2021). The effect of fasting and energy-restricting diets on markers of glucose and insulin control: A systematic review and meta-analysis of randomized controlled trials. Critical Reviews in Food Science and Nutrition, 61(20), 3383–3394. https://doi.org/10.1080/10408398.2020.1798350

3. Styne, D. M., Arslanian, S. A., Connor, E. L., et al. (2017). Pediatric obesity—Assessment, treatment, and prevention: An Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, 102(3), 709–757. https://doi.org/10.1210/jc.2016-2573

4. Chiriacò, M., Tricò, D., Petrie, J. R., et al. (2025). Impact of overweight and obesity on fasting insulin secretion in men and women without diabetes: Effect sizes and mechanisms. Diabetologia. https://doi.org/10.1007/s00125-025-06643-9

5. Sun, M. L., Yao, W., Wang, X. Y., et al. (2024). Intermittent fasting and health outcomes: An umbrella review of systematic reviews and meta-analyses of randomised controlled trials. EClinicalMedicine, 70, 102519. https://doi.org/10.1016/j.eclinm.2024.102519